Disease Landscape and Forecast 인사이트
종합적인 시장 정보와 실행 가능한 인사이트를 통해 장기적인 질병 전략을 최적화하세요.
Novel Classes of Biologics vs. TNF-Alpha Inhibitors for Crohn’s Disease and Ulcerative Colitis | Physician & Payer Forum | US | 2015
Crohn’s disease (CD) and ulcerative colitis (UC) are the two gastrointestinal inflammatory disorders that constitute inflammatory bowel disease (IBD), affecting approximately 1.25 million people…
Neuropathic Pain (Emerging brands and increasing generic competition in Neuropathic Pain) | Physician & Payer Forum | US | 2015
Neuropathic pain (NP) is a prominent form of pain associated with a variety of diseases and conditions, including cancer, diabetes, herpes zoster, chronic back pain, and multiple sclerosis. A…
Evolution of the Rheumatoid Arthritis Treatment Paradigm | Physician & Payer Forum | EU5 | 2015
The entrenched positioning of biologics (in particular, tumor necrosis factor-alpha [TNF-alpha] inhibitors) to treat moderate-to-severe rheumatoid arthritis (RA) has generated a multi-billion-…